BRAF and lung carcinoma: We also observed a strong negative correlation between PLK1 and FGFR3 in EGFR‐mutant lung cancer cohort (Appendix Fig S3D), whereas there are no such correlations in BRAF‐mutant lung cancer (Appendix Fig S3E).